Email Updates

Search form

You are here

AVAC in the News

  • The need for PrEP to be used in conjunction with condoms was highlighted when scientists announced that a second man taking the daily HIV-prevention pill had contracted a rare, drug-resistant strain of the virus.

    October 20, 2016
  • This is the second case of a man on Truvada, the once-a-day pill that’s highly effective at preventing HIV, contracting a rare drug-resistant strain of the virus.

    October 19, 2016
    Buzz Feed
  • The next generation of biomedical HIV prevention will be a hot topic here at HIV Research for Prevention (HIVR4P) 2016. Long-acting novel antiretrovirals delivered through shots or implants, vaginal rings loaded with antiretrovirals and hormonal contraception, infusions of antibodies against HIV and new HIV vaccines are all on the table—and in the works.

    October 12, 2016
  • "Vaccine developers will insert pieces of HIV in the vaccine candidate. You can't become infected from the vaccine. They insert snippets that will help the body react to the virus," explained Mitchell Warren, the executive director of AVAC, a New York City-based NGO that advocates for the accelerated ethical development of HIV vaccine and prevention options.

    October 3, 2016
    The Body
  • Clinical trials for an HIV cure need a comprehensive, transparent engagement plan that includes educating all possible stakeholders, said Jessica Salzwedel of AVAC during a recent Stakeholder Engagement webinar based on the CUREiculum, a set of tools developed by a number of HIV organizations that provide information on HIV cure research.

    September 21, 2016
  • The panel called for responsible media reporting about the HIV cure research and advised that all articles about HIV cure research results should include perspectives and quotes from independent scientists not involved in the study or studies being reported, be skeptical about any articles making claims about timelines, always cite the original science paper, avoid inflating research results and avoid speaking about “HIV cure” by itself—always include the word “research”.

    July 29, 2016
    New Vision
  • Last year, South Africa’s Medicines Control Council approved PrEP and in June this year the government began rolling it out among selected sex worker programs around the country. There are hopes it will be rolled out in the public sector by the end of the year.

    July 22, 2016
  • “When we say 'Black Lives Matter,'” said Michael Ighodaro, “Where are 'Black Gay Lives' in that?” A young, gay Nigerian refugee living with HIV in New York City, Ighodaro posed this question during a talk leading up to the International AIDS Conference (AIDS 2016).

    July 22, 2016
    Charleston Chronicle
  • Modeling data published recently by IAVI, AVAC and Avenir Health shows that a vaccine is needed to conclusively end the AIDS epidemic. These findings are particularly timely as the most recent statistics from UNAIDS show that major investments in current treatment and prevention programs have not reduced new annual HIV infections in recent years.

    July 20, 2016
    The Health Site
  • Most of the delegates at AIDS 2016 will have heard this. "Towards an HIV Cure" sessions have clearly outlined how complex the science is and how long it will take before we get there. Moreover, National Institute of Allergy and Infectious Diseases (NIAID) Director, Dr Anthony Fauci, has told POZ he believes that success on the cure front is a matter of "if" rather than "when."

    July 20, 2016
    What's Up HIV